SELLAS Life Sciences amends CEO severance terms
SELLAS Life Sciences updated the Change in Control Severance provisions in CEO Angelos Stergiou's agreement. The amendment modifies payout terms for future termination scenarios.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day